AstraZeneca/AZN
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1YMAX
About AstraZeneca
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.
Ticker
AZN
Sector
Healthcare
Trading on
LSE
Industry
Pharmaceuticals
Headquarters
Cambridge, United Kingdom
Employees
89,900
Website
www.astrazeneca.com
AstraZeneca Metrics
BasicAdvanced
£191B
Market cap
38.38
P/E ratio
£3.21
EPS
0.17
Beta
£2.30
Dividend rate
1.87%
Dividend yield
Price and volume
Market cap
£191B
Beta
0.17
Dividend rate
£2.30
Financial strength
Current ratio
0.886
Quick ratio
0.701
Long term debt to equity
75.387
Total debt to equity
92.515
Dividend payout ratio (TTM)
70.56%
Interest coverage (TTM)
8.84%
Management effectiveness
Return on assets (TTM)
7.04%
Return on equity (TTM)
17.29%
Valuation
Price to earnings (TTM)
38.38
Price to revenue (TTM)
5.06
Price to book
5.09
Price to tangible book (TTM)
-8.92
Price to free cash flow (TTM)
40.9
Dividend yield (TTM)
1.87%
Growth
Revenue change (TTM)
8.60%
Earnings per share change (TTM)
34.08%
3-year revenue growth
19.96%
3-year earnings per share growth
10.14%
3-year dividend per share growth
1.18%
What the Analysts think about AstraZeneca
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for AstraZeneca stock.
AstraZeneca Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
AstraZeneca Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
AstraZeneca News
AllArticlesVideos
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and LSEG. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for AstraZeneca stock?
AstraZeneca (AZN) has a market cap of £191B as of July 02, 2024.
What is the P/E ratio for AstraZeneca stock?
The price to earnings (P/E) ratio for AstraZeneca (AZN) stock is 38.38 as of July 02, 2024.
Does AstraZeneca stock pay dividends?
Yes, the AstraZeneca (AZN) stock pays dividends to shareholders. As of July 02, 2024, the dividend rate is £2.29549 and the yield is 1.87%. AstraZeneca has a payout ratio of 70.56% on a trailing twelve-month basis.
When is the next AstraZeneca dividend payment date?
The next AstraZeneca (AZN) dividend payment date is unconfirmed.
What is the beta indicator for AstraZeneca?
AstraZeneca (AZN) has a beta rating of 0.17. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell AstraZeneca stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.